Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
fms-Like Tyrosine Kinase 3 | 25 | 2021 | 497 | 4.980 |
Why?
|
Protein Kinase Inhibitors | 33 | 2020 | 5709 | 2.540 |
Why?
|
Leukemia, Myeloid, Acute | 24 | 2022 | 3623 | 2.290 |
Why?
|
Staurosporine | 15 | 2020 | 241 | 2.240 |
Why?
|
Fusion Proteins, bcr-abl | 16 | 2014 | 430 | 2.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 14 | 2021 | 687 | 1.790 |
Why?
|
Pyrimidines | 26 | 2019 | 3050 | 1.590 |
Why?
|
Piperazines | 19 | 2015 | 2546 | 1.460 |
Why?
|
Antineoplastic Agents | 34 | 2022 | 13708 | 1.420 |
Why?
|
Mutant Proteins | 4 | 2019 | 489 | 1.190 |
Why?
|
Drug Resistance, Neoplasm | 22 | 2019 | 5342 | 1.120 |
Why?
|
Leukemia, Myeloid | 5 | 2020 | 693 | 0.980 |
Why?
|
Small Molecule Libraries | 4 | 2021 | 746 | 0.850 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2020 | 120 | 0.820 |
Why?
|
Protein-Tyrosine Kinases | 10 | 2017 | 2434 | 0.820 |
Why?
|
Drug Repositioning | 2 | 2022 | 244 | 0.770 |
Why?
|
Phenylurea Compounds | 5 | 2020 | 532 | 0.770 |
Why?
|
Antiviral Agents | 3 | 2022 | 3063 | 0.670 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2012 | 369 | 0.660 |
Why?
|
Therapies, Investigational | 1 | 2020 | 111 | 0.660 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 467 | 0.590 |
Why?
|
Drug Screening Assays, Antitumor | 10 | 2019 | 720 | 0.590 |
Why?
|
Leukemia | 5 | 2015 | 1527 | 0.580 |
Why?
|
Cell Line, Tumor | 27 | 2022 | 17149 | 0.580 |
Why?
|
Drug Synergism | 11 | 2020 | 1765 | 0.560 |
Why?
|
Thiophenes | 2 | 2017 | 570 | 0.530 |
Why?
|
Benzothiazoles | 4 | 2020 | 248 | 0.520 |
Why?
|
Point Mutation | 4 | 2014 | 1596 | 0.520 |
Why?
|
Cell Proliferation | 23 | 2021 | 10494 | 0.520 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2964 | 0.510 |
Why?
|
Enzyme Inhibitors | 9 | 2016 | 3734 | 0.490 |
Why?
|
Mutation | 20 | 2021 | 30243 | 0.490 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2019 | 727 | 0.470 |
Why?
|
Imidazoles | 2 | 2012 | 1174 | 0.460 |
Why?
|
Tumor Cells, Cultured | 18 | 2021 | 6135 | 0.460 |
Why?
|
Apoptosis | 24 | 2021 | 9526 | 0.450 |
Why?
|
Isoquinolines | 1 | 2015 | 354 | 0.440 |
Why?
|
Stromal Cells | 4 | 2013 | 1335 | 0.440 |
Why?
|
Hematologic Neoplasms | 3 | 2022 | 1905 | 0.430 |
Why?
|
Benzamides | 15 | 2010 | 1381 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 369 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.400 |
Why?
|
Up-Regulation | 4 | 2021 | 4138 | 0.400 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2010 | 199 | 0.400 |
Why?
|
Thiazoles | 4 | 2012 | 1541 | 0.390 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 384 | 0.390 |
Why?
|
Genes, ras | 1 | 2014 | 666 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2016 | 2465 | 0.370 |
Why?
|
Molecular Structure | 8 | 2019 | 1889 | 0.360 |
Why?
|
Pyrazoles | 6 | 2021 | 2024 | 0.360 |
Why?
|
Niacinamide | 1 | 2012 | 419 | 0.350 |
Why?
|
Mice | 41 | 2024 | 82045 | 0.340 |
Why?
|
Protease Inhibitors | 4 | 2020 | 753 | 0.340 |
Why?
|
Mice, Nude | 11 | 2019 | 3635 | 0.330 |
Why?
|
Transcription Factors | 5 | 2024 | 12174 | 0.330 |
Why?
|
Carbanilides | 1 | 2008 | 18 | 0.320 |
Why?
|
Benzimidazoles | 3 | 2020 | 864 | 0.310 |
Why?
|
Signal Transduction | 21 | 2020 | 23638 | 0.310 |
Why?
|
Animals | 53 | 2024 | 169418 | 0.300 |
Why?
|
Cell Cycle | 10 | 2015 | 2942 | 0.300 |
Why?
|
Phosphorylation | 17 | 2021 | 8332 | 0.300 |
Why?
|
Pyrazines | 4 | 2021 | 1206 | 0.290 |
Why?
|
src-Family Kinases | 1 | 2010 | 539 | 0.280 |
Why?
|
Structure-Activity Relationship | 9 | 2019 | 3073 | 0.280 |
Why?
|
Multiple Myeloma | 4 | 2022 | 5192 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1766 | 0.270 |
Why?
|
Genes, abl | 1 | 2006 | 69 | 0.270 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11843 | 0.260 |
Why?
|
Aniline Compounds | 3 | 2021 | 1094 | 0.260 |
Why?
|
Receptor Protein-Tyrosine Kinases | 5 | 2013 | 1628 | 0.250 |
Why?
|
Biomimetic Materials | 1 | 2007 | 173 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2019 | 10784 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2021 | 3619 | 0.250 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2016 | 252 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2022 | 8635 | 0.240 |
Why?
|
Piperidines | 5 | 2020 | 1664 | 0.240 |
Why?
|
Histone Deacetylase Inhibitors | 4 | 2006 | 776 | 0.230 |
Why?
|
Inhibitory Concentration 50 | 4 | 2015 | 467 | 0.220 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3463 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8753 | 0.220 |
Why?
|
Bone Marrow Cells | 5 | 2013 | 2415 | 0.210 |
Why?
|
Humans | 76 | 2024 | 768451 | 0.200 |
Why?
|
Quinolines | 1 | 2008 | 769 | 0.200 |
Why?
|
Protein Kinase C | 2 | 2008 | 1207 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 4 | 2024 | 3408 | 0.200 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1839 | 0.200 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5808 | 0.200 |
Why?
|
Oligopeptides | 1 | 2007 | 1193 | 0.190 |
Why?
|
Drug Discovery | 4 | 2014 | 1062 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 979 | 0.190 |
Why?
|
Pyrroles | 2 | 2019 | 1127 | 0.180 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 617 | 0.180 |
Why?
|
Cell Survival | 8 | 2019 | 5801 | 0.180 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 168 | 0.170 |
Why?
|
Hydroxamic Acids | 5 | 2006 | 482 | 0.170 |
Why?
|
Phenylethanolamine N-Methyltransferase | 3 | 1989 | 18 | 0.170 |
Why?
|
Tyrosine | 3 | 2011 | 1428 | 0.160 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2021 | 395 | 0.160 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1644 | 0.160 |
Why?
|
Pyrimidinones | 3 | 2021 | 387 | 0.160 |
Why?
|
Xenopus Proteins | 2 | 1998 | 436 | 0.160 |
Why?
|
Cell Line | 8 | 2012 | 15609 | 0.160 |
Why?
|
Myeloproliferative Disorders | 2 | 2021 | 614 | 0.160 |
Why?
|
Models, Molecular | 10 | 2017 | 5443 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 561 | 0.150 |
Why?
|
Triazines | 1 | 2019 | 312 | 0.140 |
Why?
|
Acetamides | 1 | 2019 | 260 | 0.140 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2016 | 17 | 0.140 |
Why?
|
Leukemia, B-Cell | 1 | 2016 | 86 | 0.130 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1232 | 0.130 |
Why?
|
Ubiquitin | 2 | 2017 | 843 | 0.130 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1557 | 0.130 |
Why?
|
Naphthyridines | 1 | 2017 | 184 | 0.120 |
Why?
|
Glycogen Synthase | 1 | 2015 | 62 | 0.120 |
Why?
|
Cell Division | 7 | 2005 | 4479 | 0.120 |
Why?
|
Pyridines | 3 | 2012 | 2888 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.120 |
Why?
|
Tyrosine 3-Monooxygenase | 3 | 1992 | 370 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1608 | 0.120 |
Why?
|
Glycogen | 1 | 2015 | 252 | 0.120 |
Why?
|
K562 Cells | 4 | 2011 | 645 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 4534 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2007 | 4948 | 0.110 |
Why?
|
Burkitt Lymphoma | 1 | 2016 | 336 | 0.110 |
Why?
|
Half-Life | 2 | 2012 | 650 | 0.110 |
Why?
|
Models, Biological | 6 | 2011 | 9505 | 0.110 |
Why?
|
RNA Interference | 1 | 2022 | 2832 | 0.110 |
Why?
|
Immunoblotting | 2 | 2010 | 1650 | 0.110 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2013 | 77 | 0.110 |
Why?
|
Base Sequence | 9 | 2014 | 12428 | 0.110 |
Why?
|
Cell Growth Processes | 2 | 2010 | 383 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2002 | 2847 | 0.100 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2013 | 115 | 0.100 |
Why?
|
Adrenal Medulla | 2 | 1992 | 56 | 0.100 |
Why?
|
Histones | 2 | 2022 | 2595 | 0.100 |
Why?
|
Cell Adhesion | 3 | 2002 | 3103 | 0.100 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6241 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 639 | 0.100 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 525 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.090 |
Why?
|
Pimozide | 1 | 2011 | 21 | 0.090 |
Why?
|
Enzyme Stability | 1 | 2011 | 220 | 0.090 |
Why?
|
Oncogenes | 1 | 1997 | 1235 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 1998 | 2003 | 0.090 |
Why?
|
Protein Kinases | 3 | 2008 | 1608 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1615 | 0.090 |
Why?
|
Oleanolic Acid | 1 | 2010 | 43 | 0.090 |
Why?
|
Indazoles | 1 | 2012 | 306 | 0.090 |
Why?
|
Crystallography, X-Ray | 3 | 2016 | 1987 | 0.090 |
Why?
|
Mice, SCID | 1 | 2015 | 2633 | 0.090 |
Why?
|
STAT5 Transcription Factor | 1 | 2011 | 268 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2010 | 141 | 0.080 |
Why?
|
Cold Temperature | 2 | 1992 | 786 | 0.080 |
Why?
|
Threonine | 1 | 2010 | 274 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1909 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2015 | 12813 | 0.080 |
Why?
|
Gene Dosage | 1 | 2013 | 1221 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2004 | 3612 | 0.080 |
Why?
|
Sulfonamides | 2 | 2021 | 1988 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2010 | 342 | 0.080 |
Why?
|
Biological Products | 1 | 2017 | 937 | 0.080 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3437 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1119 | 0.070 |
Why?
|
Pyridones | 1 | 2013 | 819 | 0.070 |
Why?
|
Adenine | 3 | 2019 | 993 | 0.070 |
Why?
|
Transfection | 5 | 2002 | 5767 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2014 | 945 | 0.070 |
Why?
|
Adrenal Glands | 1 | 1989 | 557 | 0.070 |
Why?
|
Enzyme Activation | 3 | 2008 | 3594 | 0.070 |
Why?
|
Clinical Trials as Topic | 4 | 2009 | 8051 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11674 | 0.070 |
Why?
|
Phosphotyrosine | 1 | 2006 | 458 | 0.060 |
Why?
|
Cell Communication | 1 | 2013 | 1662 | 0.060 |
Why?
|
Hydrolases | 1 | 2006 | 146 | 0.060 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1744 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4294 | 0.060 |
Why?
|
Metabolomics | 1 | 2015 | 1675 | 0.060 |
Why?
|
DNA, Complementary | 3 | 2004 | 1992 | 0.060 |
Why?
|
Ubiquitination | 2 | 2020 | 1010 | 0.060 |
Why?
|
Retroviridae | 2 | 2005 | 850 | 0.060 |
Why?
|
Protein Structure, Tertiary | 5 | 2019 | 3790 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 5426 | 0.060 |
Why?
|
Genes | 3 | 2004 | 1824 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 1999 | 9623 | 0.060 |
Why?
|
Cloning, Molecular | 5 | 2004 | 4175 | 0.060 |
Why?
|
Acetylation | 2 | 2004 | 1053 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 4 | 2002 | 3735 | 0.060 |
Why?
|
Mycoplasma | 1 | 2005 | 147 | 0.060 |
Why?
|
Interleukin-3 | 2 | 2004 | 425 | 0.060 |
Why?
|
Flow Cytometry | 4 | 2015 | 5904 | 0.060 |
Why?
|
Molecular Sequence Data | 11 | 2004 | 17647 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2008 | 656 | 0.060 |
Why?
|
Binding Sites | 6 | 2019 | 6030 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3901 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2884 | 0.050 |
Why?
|
Gene Expression | 2 | 2015 | 7605 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2004 | 2751 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1170 | 0.050 |
Why?
|
Aminopeptidases | 1 | 2003 | 113 | 0.050 |
Why?
|
GATA1 Transcription Factor | 1 | 2024 | 307 | 0.050 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2003 | 105 | 0.050 |
Why?
|
Models, Chemical | 1 | 2005 | 611 | 0.050 |
Why?
|
Female | 12 | 2021 | 396943 | 0.050 |
Why?
|
Tubulin | 1 | 2006 | 695 | 0.050 |
Why?
|
Mitochondria | 1 | 1996 | 3672 | 0.050 |
Why?
|
Cell Line, Transformed | 2 | 2001 | 868 | 0.050 |
Why?
|
Hydroquinones | 1 | 2002 | 34 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2011 | 2834 | 0.050 |
Why?
|
Leucine | 1 | 2003 | 549 | 0.050 |
Why?
|
Boronic Acids | 1 | 2006 | 915 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1152 | 0.050 |
Why?
|
Amino Acid Sequence | 7 | 2016 | 13452 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 414 | 0.050 |
Why?
|
Smad2 Protein | 2 | 1998 | 144 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2008 | 2067 | 0.050 |
Why?
|
Smad Proteins | 2 | 1998 | 157 | 0.050 |
Why?
|
Trans-Activators | 3 | 2004 | 2858 | 0.050 |
Why?
|
Adamantane | 1 | 2002 | 148 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2594 | 0.040 |
Why?
|
Smad4 Protein | 2 | 1998 | 193 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 1339 | 0.040 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 182 | 0.040 |
Why?
|
Phthalazines | 1 | 2002 | 396 | 0.040 |
Why?
|
Male | 14 | 2019 | 364781 | 0.040 |
Why?
|
Xenopus | 2 | 1998 | 710 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2015 | 7895 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13589 | 0.040 |
Why?
|
Methylation | 1 | 2022 | 1077 | 0.040 |
Why?
|
Gastrula | 1 | 1998 | 83 | 0.040 |
Why?
|
Drug Resistance | 2 | 2021 | 1599 | 0.040 |
Why?
|
Nerve Growth Factors | 2 | 1998 | 566 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.040 |
Why?
|
Morpholines | 2 | 2013 | 583 | 0.040 |
Why?
|
Hydrogen Bonding | 2 | 2012 | 292 | 0.040 |
Why?
|
Smad3 Protein | 1 | 1998 | 166 | 0.040 |
Why?
|
Sirolimus | 1 | 2005 | 1542 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 387 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2702 | 0.040 |
Why?
|
Streptomyces | 1 | 2017 | 91 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10358 | 0.040 |
Why?
|
Genes, src | 1 | 1997 | 51 | 0.040 |
Why?
|
Schizosaccharomyces | 1 | 1999 | 237 | 0.030 |
Why?
|
Inhibins | 1 | 1997 | 211 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 2016 | 174 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 1997 | 120 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6320 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 1997 | 185 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 434 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2000 | 7599 | 0.030 |
Why?
|
Bone Marrow | 2 | 2003 | 2929 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4041 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 542 | 0.030 |
Why?
|
Mitochondria, Liver | 1 | 1996 | 191 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2017 | 709 | 0.030 |
Why?
|
Caspase 3 | 2 | 2010 | 732 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1999 | 908 | 0.030 |
Why?
|
Acrylamides | 1 | 2016 | 260 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2024 | 2058 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1230 | 0.030 |
Why?
|
Viral Proteins | 1 | 2002 | 1803 | 0.030 |
Why?
|
Mitochondria, Heart | 1 | 1996 | 236 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 1998 | 1625 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19041 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7246 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3520 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 6091 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4586 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2017 | 1775 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 65409 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5042 | 0.030 |
Why?
|
Cyclin D1 | 2 | 2006 | 454 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2013 | 136 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1706 | 0.030 |
Why?
|
Drug Design | 1 | 2017 | 1050 | 0.030 |
Why?
|
Rats, Inbred Strains | 2 | 1989 | 2087 | 0.020 |
Why?
|
Rats | 5 | 1996 | 23839 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1997 | 1395 | 0.020 |
Why?
|
Glycolysis | 1 | 2015 | 838 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2001 | 3611 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 817 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 1996 | 871 | 0.020 |
Why?
|
Cell Movement | 1 | 2002 | 5223 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11206 | 0.020 |
Why?
|
Precipitin Tests | 2 | 2003 | 816 | 0.020 |
Why?
|
Caspases | 2 | 2003 | 884 | 0.020 |
Why?
|
Aminopyridines | 1 | 2013 | 578 | 0.020 |
Why?
|
Cytoskeleton | 1 | 1994 | 1179 | 0.020 |
Why?
|
Kinetics | 1 | 2017 | 6348 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 1996 | 1882 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 1994 | 1136 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 1992 | 589 | 0.020 |
Why?
|
Time Factors | 3 | 2005 | 40271 | 0.020 |
Why?
|
Sequence Alignment | 2 | 2004 | 2184 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 1999 | 2680 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1992 | 1615 | 0.020 |
Why?
|
Autophagy | 1 | 2016 | 1349 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3939 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18388 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 30028 | 0.020 |
Why?
|
Carcinoma | 1 | 1999 | 2341 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 3 | 2002 | 1969 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1996 | 8201 | 0.020 |
Why?
|
Purines | 1 | 2010 | 614 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 11930 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1992 | 1415 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5803 | 0.020 |
Why?
|
Tubulin Modulators | 1 | 2006 | 107 | 0.020 |
Why?
|
Cattle | 2 | 1988 | 3830 | 0.020 |
Why?
|
Gelsolin | 1 | 2006 | 189 | 0.020 |
Why?
|
Dexamethasone | 2 | 2003 | 1965 | 0.020 |
Why?
|
Body Weight | 1 | 1996 | 4630 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2656 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22386 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59680 | 0.010 |
Why?
|
G1 Phase | 1 | 2005 | 404 | 0.010 |
Why?
|
Chromosomes, Mammalian | 1 | 2004 | 148 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2944 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1992 | 2209 | 0.010 |
Why?
|
Interleukin-6 | 2 | 2003 | 3234 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6890 | 0.010 |
Why?
|
Tumor Stem Cell Assay | 1 | 2002 | 116 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2002 | 119 | 0.010 |
Why?
|
src Homology Domains | 1 | 2003 | 362 | 0.010 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 61 | 0.010 |
Why?
|
Caspase 9 | 1 | 2002 | 185 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7449 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 326 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2002 | 455 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2003 | 427 | 0.010 |
Why?
|
Introns | 1 | 2004 | 970 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12875 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4781 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 551 | 0.010 |
Why?
|
Kidney | 1 | 1996 | 7064 | 0.010 |
Why?
|
Serpins | 1 | 2002 | 247 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2004 | 1906 | 0.010 |
Why?
|
DNA | 2 | 1997 | 7213 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
Serine | 1 | 2003 | 831 | 0.010 |
Why?
|
Pseudogenes | 1 | 1999 | 104 | 0.010 |
Why?
|
Receptors, Notch | 1 | 2004 | 752 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6978 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 560 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 665 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13047 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6278 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1869 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 835 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1674 | 0.010 |
Why?
|
Exons | 1 | 2004 | 2392 | 0.010 |
Why?
|
Indoles | 1 | 2006 | 1834 | 0.010 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2525 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 867 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1999 | 440 | 0.010 |
Why?
|
Electrophoresis | 1 | 1997 | 226 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22293 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 2298 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1322 | 0.010 |
Why?
|
Aged | 3 | 2021 | 171520 | 0.010 |
Why?
|
Central Nervous System | 1 | 2004 | 1348 | 0.010 |
Why?
|
Activins | 1 | 1997 | 211 | 0.010 |
Why?
|
Testis | 1 | 1999 | 783 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4622 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6527 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1997 | 1435 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2001 | 2003 | 0.010 |
Why?
|
NF-kappa B | 1 | 2003 | 2491 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2002 | 2096 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 1997 | 910 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5891 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2003 | 2170 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3417 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 3442 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2001 | 1614 | 0.010 |
Why?
|
Chick Embryo | 1 | 1994 | 978 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 1992 | 85 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9376 | 0.010 |
Why?
|
DNA Probes | 1 | 1992 | 542 | 0.010 |
Why?
|
Gene Deletion | 1 | 1999 | 2674 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1992 | 296 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 706 | 0.010 |
Why?
|
Epitopes | 1 | 1997 | 2526 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 223418 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8510 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1992 | 1770 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1841 | 0.010 |
Why?
|
Oligonucleotides | 1 | 1992 | 564 | 0.010 |
Why?
|
DNA Damage | 1 | 1999 | 2461 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2882 | 0.000 |
Why?
|
Plasmids | 1 | 1992 | 2269 | 0.000 |
Why?
|
Lung | 1 | 2006 | 10090 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6008 | 0.000 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1988 | 1056 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21156 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7471 | 0.000 |
Why?
|
Species Specificity | 1 | 1988 | 2422 | 0.000 |
Why?
|
Membrane Glycoproteins | 1 | 1992 | 3713 | 0.000 |
Why?
|
Adult | 1 | 2004 | 223542 | 0.000 |
Why?
|